![Janet Hopkins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Janet Hopkins
Directeur Technique/Scientifique/R&D chez
AURA BIOSCIENCES, INC.
Fortune : 448 581 $ au 31/05/2026
Profil
Janet Jill Hopkins is Director at Gyroscope Therapeutics Holdings Plc since 2022 and Chief Medical Officer at Aura Biosciences, Inc. since 2023.
Former roles include Chief Executive Officer at Gyroscope Therapeutics Ltd. from 2021 to 2023 and SVP, Global Head-Ophthalmology & Exploratory at Novartis AG from 2021 to 2023.
Education includes a doctorate from McMaster University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,1 % | 01/06/2026 | 60 051 ( 0,1 % ) | 448 581 $ | 31/05/2026 |
Postes actifs de Janet Hopkins
| Sociétés | Poste | Début |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Directeur/Membre du Conseil | 17/02/2022 |
| AURA BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 16/10/2023 |
Anciens postes connus de Janet Hopkins
| Sociétés | Poste | Fin |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01/10/2023 |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Directeur Général | 01/10/2023 |
Formation de Janet Hopkins
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
McMaster University
 McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Health Technology |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
